Good Morning! 

Markets are chopping, headlines are screaming, and most of retail is getting rinsed out of their positions.

Meanwhile, our analysts are stacking clean plays like it’s just another day in the lab.

We don’t chase pumps, we don’t panic-sell dips - we hunt precision entries with asymmetric upside and let the herd feed us liquidity.

If you’ve been sitting on the sidelines waiting for the “perfect” setup, spoiler alert: you already missed it. But don’t worry - we’ve got more lined up.

Keep reading, because today’s play is a beauty. 👇

🌡 TradingLab’s Headline Roundup

📈 Investing & Strategies

• 3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

• 1 Top Artificial Intelligence (AI) Stock Ready for a Bull Run

• Why I’m Bearish on U.S. Stocks (for the Second Time Since 2017)

🏛 Stock Markets

• S&P 500 Ticks Up 0.4% as Traders Expect Fireworks from Nvidia’s Earnings Report

• Nasdaq Futures Dive After Trump Says He’s Fired Fed’s Lisa Cook. But It’s Not That Simple

• Nvidia’s results, Indian tariffs, French markets - what’s moving markets

₿ Crypto

• Bitcoin Resumes Slide as Prices Dive to 6-Week Low Under $110,000. What’s Next?

• Crypto trader ups MEXC ‘bounty’ to $2.5M after in-person KYC request

• Crypto Industry Unites Against Senate Bill Over Protections for Software Devs

• Spot Ethereum ETFs log $455 million in daily inflows, surpassing Bitcoin ETFs for second time this week

From Italy to a Nasdaq Reservation

How do you follow record-setting success? Get stronger. Take Pacaso. Their real estate co-ownership tech set records in Paris and London in 2024. No surprise. Coldwell Banker says 40% of wealthy Americans plan to buy abroad within a year. So adding 10+ new international destinations, including three in Italy, is big. They even reserved the Nasdaq ticker PCSO.

Invest for $2.90/Share

_{Paid advertisement for Pacaso’s Regulation A offering. Read the offering circular at invest.pacaso.com. Reserving a ticker symbol is not a guarantee that the company will go public. Listing on the NASDAQ is subject to approvals.}

📈 What Am I Trading?

The Play

Sherlock spotted an opportunity on QTUM that’s too clean to ignore. Here’s the breakdown:

• Entry: Market Price ($2.966)

• DCA Level: $2.743 (50%)

• Stop Loss: $2.566 (hard stop)

• Target: $5.541

• Leverage: 5x–10x

• Rating: 7/10

Straightforward risk-reward with a nice asymmetric setup.

The Catalyst

QTUM just cracked through daily resistance while aligning with the 12 EMA, QVWAP, and YVWAP, a trifecta Sherlock doesn’t ignore. Technically, this is a textbook support breakdown flip into strength. Add in broader market momentum favoring mid-cap alts right now, and you’ve got a spark with some real firepower.

Our Take

This is a buy with teeth. The stop is tight, the upside is juicy, and QTUM has room to breathe if it clears near-term liquidity pockets. Even if the setup isn’t perfect (Sherlock rated it a 7/10), it’s the kind of trade where you blink and it’s already halfway to target.

We’re riding this one to $5.541, and if you’re still on the sidelines watching, you’re already late.

💡 Want plays like this dropped to you daily, before they move? Stop lurking, join TradingLab, and actually catch these trades while they’re hot.

🔥 These aren’t hindsight screenshots - they’re live calls with tight risk, clear targets, and the context you never get from random signal groups. If you’ve felt the frustration of missed moves, blown stops, or just gambling in the dark, this is your chance to trade with precision and confidence.

Inside TradingLab Premium, you’ll get daily plays like this one, risk-managed setups explained in plain English, and a community that actually has your back. Don’t just read about the wins - catch them while they’re happening.

👉 Join TradingLab Premium today

Stay ahead, stay informed, and most importantly, stay profitable.

‘til next time,

TradingLab